Cancer Biomarkers投稿须知

期刊简介

《Cancer Biomarkers》是由IOS Press出版社于2005年创办的英文国际期刊（ISSN: 1574-0153，E-ISSN: 1875-8592），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为ONCOLOGY。作为SCIE收录期刊（JCR分区 Q3，中科院 4区），本刊采用OA未开放获取模式（OA占比0%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比98.90%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在91篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Biomarkers审稿周期约为约3.0个月。该刊近年被列入国际预警名单，年发文量约91篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
是是否预警
SCIE 期刊收录
91 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	ONCOLOGY 肿瘤学 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	209 / 322	35.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	167 / 322	48.29%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：5.2

SJR：0.579

SNIP：0.45

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q2	158 / 404	61%
大类：Medicine 小类：Genetics	Q2	159 / 347	54%
大类：Medicine 小类：Cancer Research	Q3	130 / 230	43%

期刊发文

ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma
Author: Zou, Lianhong; Liu, Kaihua; Shi, Yongzhong; Li, Guowei; Li, Haiyang; Zhao, Chaoxian

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 299-311. DOI: 10.3233/CBM-220226
Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma
Author: Zhang, Chengpeng; Huang, Yong; Fang, Chen; Liang, Yingkuan; Jiang, Dong; Li, Jiaxi; Ma, Haitao; Jiang, Wei; Feng, Yu

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 313-326. DOI: 10.3233/CBM-220227
Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment
Author: Yin, Zi; Ma, Tingting; Chen, Sheng; Yu, Min

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 3, pp. 231-250. DOI: 10.3233/CBM-210300
LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression
Author: Yao, Weitao; Hou, Jingyu; Liu, Guoqing; Wu, Fangxing; Yan, Qiang; Guo, Liangyu; Wang, Chuchu

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 1, pp. 1-16. DOI: 10.3233/CBM-210291
MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53
Author: Yang, Yun; Luo, Yanyan; Huang, Shuting; Tao, Yonghui; Li, Chuanyin; Wang, Chengcheng

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 267-278. DOI: 10.3233/CBM-210559
Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients
Author: Wu, Mengni; Lu, Linlin; Dai, Tiantian; Li, Aoshuang; Yu, Yue; Li, Yadi; Xu, Zhihua; Chen, Yan

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 1, pp. 83-96. DOI: 10.3233/CBM-210545
Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular carcinoma
Author: Wang, Di; Hu, Huan; Ding, Huan; Zhao, Han; Tian, Feifei; Chi, Qingjia

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 2, pp. 147-159. DOI: 10.3233/CBM-210538
The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study
Author: Wang, Cheng; Lin, Tingting; Chen, Xin; Cui, Wenjing; Guo, Chuangen; Wang, Zhongqiu; Chen, Xiao

Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 279-286. DOI: 10.3233/CBM-220080

Cancer Biomarkers

癌症生物标志物

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询